<DOC>
	<DOCNO>NCT00037479</DOCNO>
	<brief_summary>The purpose study determine whether patient persistent memory problem Lyme disease benefit additional long course IV antibiotic therapy ; use modern brain imaging technology determine whether problem central nervous system primarily one poor blood flow one impaired nerve cell functioning ; try identify biological marker prior treatment identify patient less likely respond study treatment .</brief_summary>
	<brief_title>Brain Imaging Retreatment Study Persistent Lyme Disease</brief_title>
	<detailed_description>Some people history Lyme disease continue problem despite receive “ textbook duration ” antibiotic therapy . When memory , attention , think problem persist , syndrome call persistent Lyme disease ( PLD ) . This study seek answer critical scientific question treatment cause PLD symptom . This 24-week treatment study evaluate patient ’ response treatment use neuropsychological test state-of-the-art brain imaging . The brain test include neuropsychological test memory attention , brain imaging ( MRI PET scan ) look blood flow brain nerve cell structure metabolism , neurological exam , study fluid surround brain ( cerebrospinal fluid ) . The treatment involve 10 week either intravenous antibiotic call ceftriaxone ( also know Rocephin ) intravenous placebo ( inactive substance ) . After first visit Columbia Presbyterian Medical Center , remain treatment do patient ’ home . Patients screen phone person confirm study eligibility .</detailed_description>
	<mesh_term>Lyme Disease</mesh_term>
	<mesh_term>Lyme Neuroborreliosis</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<criteria>Eligible participant must : Be 1865 year old Have persistent problem memory , verbal fluency , attention contract Lyme disease . Be able travel New York 45 evaluation course one year . Travel cost participant need may partially fully reimbursable . Have history welldocumented Lyme disease use CDC 's clinical criterion current positive IgG Western blot PCR . Have receive , point past least 3 week IV antibiotic therapy Lyme disease . Ineligible participation people follow : Other major medical neurologic problem Smoke 10 cigarette day Uncontrolled high blood pressure Allergy ceftriaxone ( Rocephin ) History mark cocaine abuse Twenty healthy subject also seek study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2005</verification_date>
	<keyword>neurologic Lyme disease</keyword>
	<keyword>Lyme disease</keyword>
	<keyword>ceftriaxone</keyword>
	<keyword>Rocephin</keyword>
	<keyword>PET scan</keyword>
	<keyword>Lyme encephalopathy</keyword>
	<keyword>neuroborreliosis</keyword>
	<keyword>borreliosis</keyword>
</DOC>